
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


Modular Medical Inc (MODD)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: MODD (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $8
1 Year Target Price $8
1 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -51.28% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 38.67M USD | Price to earnings Ratio - | 1Y Target Price 8 |
Price to earnings Ratio - | 1Y Target Price 8 | ||
Volume (30-day avg) 1 | Beta -4.99 | 52 Weeks Range 0.63 - 2.50 | Updated Date 09/17/2025 |
52 Weeks Range 0.63 - 2.50 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.51 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -111.54% | Return on Equity (TTM) -215.41% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 34521815 | Price to Sales(TTM) - |
Enterprise Value 34521815 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA -3.21 | Shares Outstanding 55274600 | Shares Floating 44309774 |
Shares Outstanding 55274600 | Shares Floating 44309774 | ||
Percent Insiders 5.76 | Percent Institutions 38.87 |
Upturn AI SWOT
Modular Medical Inc

Company Overview
History and Background
Modular Medical, Inc. is a medical device company focused on the development and commercialization of easy-to-use and affordable diabetes technology. Founded to address the limitations of existing continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems, the company aims to create accessible and user-friendly solutions for managing diabetes.
Core Business Areas
- Insulin Delivery Systems: Development of a novel, modular insulin pump designed for ease of use and affordability.
- Continuous Glucose Monitoring (CGM) Integration: Integration of the insulin pump with CGM devices for closed-loop automated insulin delivery.
Leadership and Structure
Details on the specific leadership team and organizational structure are generally available on their investor relations website or company profile pages. Specific names and titles would need to be pulled directly from those sources.
Top Products and Market Share
Key Offerings
- Insulin Pump (Under Development): Modular Medical is developing a novel insulin pump designed for affordability and ease of use. As the pump is still under development, it does not currently have market share or revenue. Competitors include Medtronic (MDT), Insulet (PODD), and Tandem Diabetes Care (TNDM).
Market Dynamics
Industry Overview
The diabetes management market is experiencing significant growth, driven by the increasing prevalence of diabetes and advancements in technology such as CGM and automated insulin delivery systems. Key trends include miniaturization of devices, enhanced connectivity, and improved user interfaces.
Positioning
Modular Medical aims to disrupt the diabetes management market by offering a more affordable and user-friendly insulin pump solution. They are positioning themselves as a value-driven alternative to established players.
Total Addressable Market (TAM)
The global diabetes care devices market is estimated to be in the billions of USD. Modular Medical's TAM is tied to the portion of that market served by insulin pumps. Their positioning aims to increase market penetration among price-sensitive patients.
Upturn SWOT Analysis
Strengths
- Innovative product design (modular, user-friendly)
- Focus on affordability
- Potential for disruption in the insulin pump market
- Experienced management team (Requires verification of this information)
Weaknesses
- Product still under development
- Limited funding and resources compared to established players
- No current revenue stream
- Dependence on regulatory approvals
Opportunities
- Growing demand for diabetes management solutions
- Increasing adoption of CGM and automated insulin delivery systems
- Partnerships with diabetes clinics and healthcare providers
- Expansion into international markets
Threats
- Competition from established players with significant resources
- Regulatory hurdles and approval delays
- Technological advancements by competitors
- Reimbursement challenges from insurance providers
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Insulet (PODD)
- Tandem Diabetes Care (TNDM)
Competitive Landscape
Modular Medical aims to compete on price and ease of use. Established players have significant resources and market share, but Modular Medical's innovative design could attract price-sensitive customers.
Growth Trajectory and Initiatives
Historical Growth: No historical revenue growth due to the pre-revenue stage of the company.
Future Projections: Future growth is contingent on successful product launch and market penetration. Analyst estimates (if available) would be highly speculative at this stage.
Recent Initiatives: Recent initiatives likely include ongoing product development, clinical trials, and seeking regulatory approvals.
Summary
Modular Medical is an early-stage medical device company with the potential to disrupt the diabetes management market with its affordable and user-friendly insulin pump. The company faces significant challenges, including competition from established players, regulatory hurdles, and the need to secure additional funding. Their innovative design and focus on affordability could be a key differentiator. Securing FDA approval will be a critical milestone for future growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Analyst Reports (where available)
Disclaimers:
This analysis is based on publicly available information and represents an opinion. Investment decisions should be made after consulting with a qualified financial advisor. Market share data is estimated and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Modular Medical Inc
Exchange NASDAQ | Headquaters San Diego, CA, United States | ||
IPO Launch date 2007-01-25 | CEO - | ||
Sector Healthcare | Industry Medical Devices | Full time employees 53 | Website https://www.modularmedical.com |
Full time employees 53 | Website https://www.modularmedical.com |
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It also offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. Modular Medical, Inc. is headquartered in San Diego, California.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.